MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 679-684

  Han, Gang ^a   Wang, Yan ^a   Bi, Wenzhi ^a   Jia, Jinpeng ^a   Wang, Wei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; microRNA 124; Migration; Osteosarcoma; Prognosis; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MICRORNA 124;

ADJUVANT CHEMOTHERAPY; ADULT; APOPTOSIS; ARTICLE; BONE BIOPSY; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MTT ASSAY; OSTEOSARCOMA; OSTEOSARCOMA CELL LINE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 84922008640     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.2161     Document Type: Article

References (31)

1. Mirabello L, Troisi RJ and Savage SA: Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115: 1531-1543, 2009.
2. Marina N, Gebhardt M, Teot L and Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422-441, 2004.
3. Eppert K, Wunder JS, Aneliunas V, Kandel R and Andrulis IL: von Willebrand factor expression in osteosarcoma metastasis. Mod Pathol 18: 388-397, 2005.
4. Osman A: MicroRNAs in health and disease -basic science and clinical applications. Clin Lab 58: 393-402, 2012.
5. Zhao G, Cai C, Yang T, et al: MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 8: e53906, 2013.
6. Mendell JT and Olson EN: MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187, 2012.
7. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
8. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
9. Dieckmann KP, Spiekermann M, Balks T, et al: MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107: 1754-1760, 2012.
10. Takahashi M, Cuatrecasas M, Balaguer F, et al: The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One 7: e46684, 2012.
11. Yang C, Hou C, Zhang H, et al: miR-126 functions as a tumor suppressor in osteosarcoma by targeting Sox2. Int J Mol Sci 15: 423-437, 2014.
12. Zhao H, Li M, Li L, et al: MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One 8: e83571, 2013.
13. Wang Z, Cai H, Lin L, Tang M and Cai H: Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Pediatr Blood Cancer 61: 206-210, 2014.
14. Tang M, Lin L, Cai H, Tang J and Zhou Z: MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma. Onco Targets Ther 6: 833-838, 2013.
15. Zhou Y, Huang Z, Wu S, et al: miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J Exp Clin Cancer Res 33: 12, 2014.
16. Chandrasekar V and Dreyer JL: microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol Cell Neurosci 42: 350-362, 2009.
17. Li KK, Pang JC, Ching AK, et al: miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243, 2009.
18. Liang YJ, Wang QY, Zhou CX, et al: MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis 34: 713-722, 2013.
19. Zhang H, Wang Q, Zhao Q and Di W: MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res 6: 84, 2013.
20. Wilting SM, van Boerdonk RA, Henken FE, et al: Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Mol Cancer 9: 167, 2010.
21. Xia J, Wu Z, Yu C, et al: miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 227: 470-480, 2012.
22. Zhang J, Lu Y, Yue X, et al: MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 8: e70300, 2013.
23. Zheng F, Liao YJ, Cai MY, et al: The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289, 2012.
24. Wang P, Chen L, Zhang J, et al: Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene 33: 514-524, 2014.
25. Shi XB, Xue L, Ma AH, et al: Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene 32: 4130-4138, 2013.
26. Enneking WF, Spanier SS and Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res, 106-120, 1980.
27. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221-1230, 1982.
28. Chen X, Chen J, Gan S, et al: DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biol 11: 73, 2013.
29. Deng X, Ma L, Wu M, et al: miR-124 radiosensitizes human glioma cells by targeting CDK4. J Neurooncol 114: 263-274, 2013.
30. Brennecke J, Stark A, Russell RB and Cohen SM: Principles of microRNA-target recognition. PLoS Biol 3: e85, 2005.
31. Krek A, Grün D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37: 495-500, 2005.